Save your place

Sign in to WhoBought

Please try again later.

Monopar Therapeutics Inc. (MNPR) institutional ownership

Market cap$249M SectorHealthcare
Funds holding · Q3 2024
12
reported MNPR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q3 2024
Activity unavailable N/A
0 buyers · 12 sellers

Monopar Therapeutics Inc. (MNPR) price and institutional activity

Dates

Q3 2024

$0 bought by 0 investors
$0 sold by 12 investors
Millennium Management LLCGeode +10 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Monopar Therapeutics Inc. (MNPR) institutional activity · 12

Investor Type Est. change Change Δ Own Date
Millennium Management LLC · Exited
Change −194K Δ Own −100.0% Date Q3 2024
Millennium Management LLC Exited· Q3 2024 −194K −100.0% Q3 2024
Geode · Exited
Change −60K Δ Own −100.0% Date Q3 2024
Geode Exited· Q3 2024 −60K −100.0% Q3 2024
Two Sigma Securities, LLC · Exited
Change −47K Δ Own −100.0% Date Q3 2024
Two Sigma Securities, LLC Exited· Q3 2024 −47K −100.0% Q3 2024
Vanguard · Exited
Change −45K Δ Own −100.0% Date Q3 2024
Vanguard Exited· Q3 2024 −45K −100.0% Q3 2024
Gerber, LLC · Exited
Change −28K Δ Own −100.0% Date Q3 2024
Gerber, LLC Exited· Q3 2024 −28K −100.0% Q3 2024
Virtu Financial LLC · Exited
Change −19K Δ Own −100.0% Date Q3 2024
Virtu Financial LLC Exited· Q3 2024 −19K −100.0% Q3 2024
Rappaport Reiches Capital Management, LLC · Exited
Change −11K Δ Own −100.0% Date Q3 2024
Rappaport Reiches Capital Management, LLC Exited· Q3 2024 −11K −100.0% Q3 2024
Tower Research Capital LLC (trc) · Exited
Change −8K Δ Own −100.0% Date Q3 2024
Tower Research Capital LLC (trc) Exited· Q3 2024 −8K −100.0% Q3 2024
Newedge Advisors, LLC · Exited
Change −3K Δ Own −100.0% Date Q3 2024
Newedge Advisors, LLC Exited· Q3 2024 −3K −100.0% Q3 2024
Wells Fargo & Company · Exited
Change −2K Δ Own −100.0% Date Q3 2024
Wells Fargo & Company Exited· Q3 2024 −2K −100.0% Q3 2024
Bank of America Corp · Exited
Change −561 Δ Own −100.0% Date Q3 2024
Bank of America Corp Exited· Q3 2024 −561 −100.0% Q3 2024
Federation des Caisses Desjardins du Quebec · Exited
Change −80 Δ Own −100.0% Date Q3 2024
Federation des Caisses Desjardins du Quebec Exited· Q3 2024 −80 −100.0% Q3 2024
Data through Q3 2024 · filed Q3 2024
12 of 12

Famous investor activity in Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Inc. (MNPR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Vu Quan Anh · Officer 2 operations 0
Owned 9K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Vu Quan Anh Officer 2 operations 0 9K Jun 30, 2026 Jul 2, 2026
Vu Quan Anh · Officer Tax withholding or exercise payment (F) -$47K
Price $92.59 Qty -507 Owned 2K ΔOwn −18.6% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Vu Quan Anh Officer Tax withholding or exercise payment (F) $92.59 -507 -$47K 2K −18.6% Jun 30, 2026 Jul 2, 2026
Robinson Chandler · Director 2 operations 0
Owned 93K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Robinson Chandler Director 2 operations 0 93K Jun 30, 2026 Jul 2, 2026
Robinson Chandler · Director Tax withholding or exercise payment (F) -$378K
Price $92.59 Qty -4K Owned 99K ΔOwn −4.0% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Robinson Chandler Director Tax withholding or exercise payment (F) $92.59 -4K -$378K 99K −4.0% Jun 30, 2026 Jul 2, 2026
Cittadine Andrew · Officer 2 operations 0
Owned 39K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Cittadine Andrew Officer 2 operations 0 39K Jun 30, 2026 Jul 2, 2026
Cittadine Andrew · Officer Tax withholding or exercise payment (F) -$214K
Price $92.59 Qty -2K Owned 56K ΔOwn −4.0% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Cittadine Andrew Officer Tax withholding or exercise payment (F) $92.59 -2K -$214K 56K −4.0% Jun 30, 2026 Jul 2, 2026
Sweeny Nicole · Director Grant (A) 1K
Owned 1K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Sweeny Nicole Director Grant (A) 1K 1K Jun 26, 2026 Jun 30, 2026
Robinson Chandler · Director 2 operations 0
Owned 106K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Robinson Chandler Director 2 operations 0 106K Mar 31, 2026 Apr 2, 2026
Robinson Chandler · Director Tax withholding or exercise payment (F) -$108K
Price $54.79 Qty -2K Owned 90K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Robinson Chandler Director Tax withholding or exercise payment (F) $54.79 -2K -$108K 90K Mar 31, 2026 Apr 2, 2026
Cittadine Andrew · Officer 2 operations 0
Owned 45K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Cittadine Andrew Officer 2 operations 0 45K Mar 31, 2026 Apr 2, 2026
Cittadine Andrew · Officer Tax withholding or exercise payment (F) -$86K
Price $54.79 Qty -2K Owned 53K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Cittadine Andrew Officer Tax withholding or exercise payment (F) $54.79 -2K -$86K 53K Mar 31, 2026 Apr 2, 2026
Rodriguez Susan · Officer Grant (A) 49K
Owned 49K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Rodriguez Susan Officer Grant (A) 49K 49K Mar 2, 2026 Mar 4, 2026
Rioux Patrice · Other Grant (A) 2K
Owned 2K Trade date Jan 1, 2026 Filed date Jan 5, 2026
Rioux Patrice Other Grant (A) 2K 2K Jan 1, 2026 Jan 5, 2026
Robinson Chandler · Director, Officer 2 operations 0
Owned 113K Trade date Dec 31, 2025 Filed date Jan 5, 2026
Robinson Chandler Director, Officer 2 operations 0 113K Dec 31, 2025 Jan 5, 2026
Robinson Chandler · Director, Officer Tax withholding or exercise payment (F) -$167K
Price $65.30 Qty -3K Owned 86K Trade date Dec 31, 2025 Filed date Jan 5, 2026
Robinson Chandler Director, Officer Tax withholding or exercise payment (F) $65.30 -3K -$167K 86K Dec 31, 2025 Jan 5, 2026
15 of 34
15 of 34 Sign in to continue to older insider transactions.

Monopar Therapeutics Inc. (MNPR) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Tactic Pharma LLC 856K
% of shares outstanding 16.2% Filing date Dec 17, 2024
Tactic Pharma LLC 856K 16.2% Dec 17, 2024
Janus Henderson Group PLC 562K
% of shares outstanding 10.9% Filing date Nov 6, 2024
Janus Henderson Group PLC 562K 10.9% Nov 6, 2024
Astrazeneca PLC 387K
% of shares outstanding 9.9% Filing date Oct 28, 2024
Astrazeneca PLC 387K 9.9% Oct 28, 2024
Adage Capital Management, L.P. 424K
% of shares outstanding 6.2% Filing date May 13, 2026
Adage Capital Management, L.P. 424K 6.2% May 13, 2026
Saturn V Capital Management LP 346K
% of shares outstanding 5.2% Filing date May 15, 2026
Saturn V Capital Management LP 346K 5.2% May 15, 2026
Tang Capital Management LLC 200K
% of shares outstanding 5.1% Filing date Oct 24, 2024
Tang Capital Management LLC 200K 5.1% Oct 24, 2024
6 of 6

Monopar Therapeutics Inc. (MNPR) ownership FAQ

Who owns MNPR?

12 reporting institutions disclosed MNPR position changes in the Q3 2024 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q3 2024.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.